Mylan N.V., a global pharmaceutical company, has launched bexarotene 75mg capsules in US, which is the generic version of Valeant's Targretin capsules. The product is indicated for the treatment of cutaneous manifestations of cutaneous t-cell lymphoma in patients who are refractory to at least one prior systemic therapy.

